Anterior Segment OCT Biomarkers in Early Postoperative Phase Show No Predictive Value for Secondary Interventions Following Preserflo MicroShunt Surgery - Takeaways - MDSpire

Anterior Segment OCT Biomarkers in Early Postoperative Phase Show No Predictive Value for Secondary Interventions Following Preserflo MicroShunt Surgery

  • By

  • Martin Kallab

  • Sarah Hinterberger

  • Sophie Schneider

  • Olivia Murauer

  • Anna-Sophie Reisinger

  • Susanne Strohmaier

  • Alex S. Huang

  • Matthias Bolz

  • Clemens A. Strohmaier

  • April 23, 2026

  • 0 min

Share

  • 1

    The study evaluated AS-OCT parameters BWT and TBH for predicting secondary interventions after Preserflo MicroShunt surgery.

  • 2

    In a cohort of 23 glaucoma patients, 10 required secondary interventions between 4 and 48 weeks post-surgery.

  • 3

    Neither BWT nor TBH showed significant association with future secondary interventions at 1, 2, or 4 weeks postoperatively.

  • 4

    BVD was identified as a better predictor for secondary interventions compared to BWT and TBH in the same patient cohort.

  • 5

    The findings suggest the need for larger studies to confirm the predictive value of AS-OCT parameters after PM implantation.

Original Source(s)

Anterior Segment OCT Biomarkers in Early Postoperative Phase Show No Predictive Value for Secondary Interventions Following Preserflo MicroShunt Surgery

  • by Martin Kallab, Sarah Hinterberger, Sophie Schneider, Olivia Murauer, Anna-Sophie Reisinger, Susanne Strohmaier, Alex S. Huang, Matthias Bolz, Clemens A. Strohmaier

  • April 23, 2026

Related Content

Patient experience of and barriers to the eye examination

Integrating EyeCare

As demand for ophthalmic services surges, EyeCare Partners is building a physician-led network designed to meet rising clinical and research needs

  • April 20, 2026

  • 10 min
FOXC1 Duplications Linked to Early-Onset Glaucoma

FOXC1 duplications were the second most common monogenic finding among genetically solved juvenile open-angle glaucoma cases in one registry, supporting the use of copy-number variant analysis in early-onset glaucoma testing.